Published in Aperito J Cell Mol Biol on December 08, 2014
Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction. Arq Bras Cardiol (2017) 0.75
Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med (2006) 7.24
CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging (2014) 4.71
Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med (2013) 3.97
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol (2004) 3.43
Amyloidosis. Annu Rev Med (2006) 3.27
Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des (2008) 1.55
Senile systemic amyloidosis: clinical features at presentation and outcome. J Am Heart Assoc (2013) 1.20
Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing. Am J Surg Pathol (2011) 0.99
Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis. Amyloid (2013) 0.89
Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data. Am J Perinatol (2015) 0.76
Characterization of Mast Cell Activation Syndrome. Am J Med Sci (2016) 0.75
Cases of transfusion-transmitted babesiosis occurring in nonendemic areas: a diagnostic dilemma. Transfusion (2017) 0.75
Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab. J Am Acad Dermatol (2014) 0.75